These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

429 related articles for article (PubMed ID: 10559303)

  • 1. The residues between the two transformation effector sites of Epstein-Barr virus latent membrane protein 1 are not critical for B-lymphocyte growth transformation.
    Izumi KM; Cahir McFarland ED; Riley EA; Rizzo D; Chen Y; Kieff E
    J Virol; 1999 Dec; 73(12):9908-16. PubMed ID: 10559303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Epstein-Barr virus oncogene product latent membrane protein 1 engages the tumor necrosis factor receptor-associated death domain protein to mediate B lymphocyte growth transformation and activate NF-kappaB.
    Izumi KM; Kieff ED
    Proc Natl Acad Sci U S A; 1997 Nov; 94(23):12592-7. PubMed ID: 9356494
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of TRAF1, TRAF2, and TRAF3 with an Epstein-Barr virus LMP1 domain important for B-lymphocyte transformation: role in NF-kappaB activation.
    Devergne O; Hatzivassiliou E; Izumi KM; Kaye KM; Kleijnen MF; Kieff E; Mosialos G
    Mol Cell Biol; 1996 Dec; 16(12):7098-108. PubMed ID: 8943365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epstein-Barr virus-encoded latent membrane protein 1 activates the JNK pathway through its extreme C terminus via a mechanism involving TRADD and TRAF2.
    Eliopoulos AG; Blake SM; Floettmann JE; Rowe M; Young LS
    J Virol; 1999 Feb; 73(2):1023-35. PubMed ID: 9882303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Epstein-Barr virus oncoprotein latent membrane protein 1 engages the tumor necrosis factor receptor-associated proteins TRADD and receptor-interacting protein (RIP) but does not induce apoptosis or require RIP for NF-kappaB activation.
    Izumi KM; Cahir McFarland ED; Ting AT; Riley EA; Seed B; Kieff ED
    Mol Cell Biol; 1999 Aug; 19(8):5759-67. PubMed ID: 10409763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TRAF1 Coordinates Polyubiquitin Signaling to Enhance Epstein-Barr Virus LMP1-Mediated Growth and Survival Pathway Activation.
    Greenfeld H; Takasaki K; Walsh MJ; Ersing I; Bernhardt K; Ma Y; Fu B; Ashbaugh CW; Cabo J; Mollo SB; Zhou H; Li S; Gewurz BE
    PLoS Pathog; 2015 May; 11(5):e1004890. PubMed ID: 25996949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An Epstein-Barr virus that expresses only the first 231 LMP1 amino acids efficiently initiates primary B-lymphocyte growth transformation.
    Kaye KM; Izumi KM; Li H; Johannsen E; Davidson D; Longnecker R; Kieff E
    J Virol; 1999 Dec; 73(12):10525-30. PubMed ID: 10559372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Epstein-Barr virus LMP1 amino acid sequence that engages tumor necrosis factor receptor associated factors is critical for primary B lymphocyte growth transformation.
    Izumi KM; Kaye KM; Kieff ED
    Proc Natl Acad Sci U S A; 1997 Feb; 94(4):1447-52. PubMed ID: 9037073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The A20 protein interacts with the Epstein-Barr virus latent membrane protein 1 (LMP1) and alters the LMP1/TRAF1/TRADD complex.
    Fries KL; Miller WE; Raab-Traub N
    Virology; 1999 Nov; 264(1):159-66. PubMed ID: 10544141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TRADD domain of Epstein-Barr virus transforming protein LMP1 is essential for inducing immortalization and suppressing senescence of primary rodent fibroblasts.
    Xin B; He Z; Yang X; Chan CP; Ng MH; Cao L
    J Virol; 2001 Mar; 75(6):3010-5. PubMed ID: 11222727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TRAF1 is a critical regulator of JNK signaling by the TRAF-binding domain of the Epstein-Barr virus-encoded latent infection membrane protein 1 but not CD40.
    Eliopoulos AG; Waites ER; Blake SM; Davies C; Murray P; Young LS
    J Virol; 2003 Jan; 77(2):1316-28. PubMed ID: 12502848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epstein-Barr virus-encoded LMP1 and CD40 mediate IL-6 production in epithelial cells via an NF-kappaB pathway involving TNF receptor-associated factors.
    Eliopoulos AG; Stack M; Dawson CW; Kaye KM; Hodgkin L; Sihota S; Rowe M; Young LS
    Oncogene; 1997 Jun; 14(24):2899-916. PubMed ID: 9205097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel dominant-negative mutant form of Epstein-Barr virus latent membrane protein-1 (LMP1) selectively and differentially impairs LMP1 and TNF signaling pathways.
    Adriaenssens E; Mougel A; Goormachtigh G; Loing E; Fafeur V; Auriault C; Coll J
    Oncogene; 2004 Apr; 23(15):2681-93. PubMed ID: 14767477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Epstein-Barr virus LMP1 cytoplasmic carboxy terminus is essential for B-lymphocyte transformation; fibroblast cocultivation complements a critical function within the terminal 155 residues.
    Kaye KM; Izumi KM; Mosialos G; Kieff E
    J Virol; 1995 Feb; 69(2):675-83. PubMed ID: 7815530
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL-1 receptor-associated kinase 1 is critical for latent membrane protein 1-induced p65/RelA serine 536 phosphorylation and NF-kappaB activation.
    Song YJ; Jen KY; Soni V; Kieff E; Cahir-McFarland E
    Proc Natl Acad Sci U S A; 2006 Feb; 103(8):2689-94. PubMed ID: 16477006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LMP1 TRAFficking activates growth and survival pathways.
    Soni V; Cahir-McFarland E; Kieff E
    Adv Exp Med Biol; 2007; 597():173-87. PubMed ID: 17633026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unique signaling properties of CTAR1 in LMP1-mediated transformation.
    Mainou BA; Everly DN; Raab-Traub N
    J Virol; 2007 Sep; 81(18):9680-92. PubMed ID: 17626074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epstein-Barr virus-mediated B-cell proliferation is dependent upon latent membrane protein 1, which simulates an activated CD40 receptor.
    Kilger E; Kieser A; Baumann M; Hammerschmidt W
    EMBO J; 1998 Mar; 17(6):1700-9. PubMed ID: 9501091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor necrosis factor receptor associated factor 2 is a mediator of NF-kappa B activation by latent infection membrane protein 1, the Epstein-Barr virus transforming protein.
    Kaye KM; Devergne O; Harada JN; Izumi KM; Yalamanchili R; Kieff E; Mosialos G
    Proc Natl Acad Sci U S A; 1996 Oct; 93(20):11085-90. PubMed ID: 8855313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Residues 231 to 280 of the Epstein-Barr virus nuclear protein 2 are not essential for primary B-lymphocyte growth transformation.
    Harada S; Yalamanchili R; Kieff E
    J Virol; 1998 Dec; 72(12):9948-54. PubMed ID: 9811732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.